Details of the Drug

General Information of Drug (ID: DMXFTDF)

Drug Name

CaCP-29

Indication

Disease Entry	ICD 11	Status	REF
Sepsis	1G40-1G41	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02246595) Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction. U.S. National Institutes of Health.